Yayın: Ten Year Hepatitis A, B, And C Seroprevalence Trend in Children: Results From A Single Center
| dc.contributor.author | YILDIZ, Eren | |
| dc.contributor.author | NARSAT, Mehmet Ali | |
| dc.date.accessioned | 2026-01-04T17:15:29Z | |
| dc.date.issued | 2022-09-22 | |
| dc.description.abstract | Aim: Hepatitis B vaccination since 1998 and hepatitis A vaccination since 2012 is available in the childhood routine vaccination program in Turkey. There is no vaccine for hepatitis C yet. The seroprevalence of hepatitis A, B, and C differs between regions. For this reason, each region should assemble its own rates. Therefore, this study aimed to determine the seroprevalence of hepatitis A, B, and C in children in Kastamonu province, to evaluate whether there is a change in prevalence according to years and patient age, and to review whether there is a change in hepatitis A virus seroprevalence with hepatitis A vaccination. Material and Methods: File records of all patients under 18 whose hepatitis serology was studied at Kastamonu Training and Research Hospital between 01.01.2012 and 21.12.2021 were reviewed retrospectively. Results: A total of 19885 patients and 55738 test results were included in the study. Accordingly, hepatitis A seroprevalence increased year by year. Anti-HAV IgG positivity was higher in the vaccinated group, whereas anti-HAV IgM positivity was higher in the unvaccinated group (p | |
| dc.description.uri | https://doi.org/10.37990/medr.1159364 | |
| dc.identifier.doi | 10.37990/medr.1159364 | |
| dc.identifier.eissn | 2687-4555 | |
| dc.identifier.endpage | 497 | |
| dc.identifier.openaire | doi_dedup___::9c460e8e3a22c5c3fe5f8adead5140f3 | |
| dc.identifier.orcid | 0000-0002-8056-5727 | |
| dc.identifier.orcid | 0000-0002-6496-1965 | |
| dc.identifier.startpage | 493 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/40002 | |
| dc.identifier.volume | 4 | |
| dc.publisher | Medical Records - International Medical Journal | |
| dc.relation.ispartof | Medical Records | |
| dc.rights | OPEN | |
| dc.subject.sdg | 3. Good health | |
| dc.title | Ten Year Hepatitis A, B, And C Seroprevalence Trend in Children: Results From A Single Center | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.api.response | {"authors":[{"fullName":"Eren YILDIZ","name":"Eren","surname":"YILDIZ","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0002-8056-5727"},"provenance":null}},{"fullName":"Mehmet Ali NARSAT","name":"Mehmet Ali","surname":"NARSAT","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0002-6496-1965"},"provenance":null}}],"openAccessColor":"gold","publiclyFunded":false,"type":"publication","language":{"code":"und","label":"Undetermined"},"countries":null,"subjects":[{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"FOS","value":"0302 clinical medicine"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"Ten Year Hepatitis A, B, And C Seroprevalence Trend in Children: Results From A Single Center","subTitle":null,"descriptions":["<jats:p xml:lang=\"en\">Aim: Hepatitis B vaccination since 1998 and hepatitis A vaccination since 2012 is available in the childhood routine vaccination program in Turkey. There is no vaccine for hepatitis C yet. The seroprevalence of hepatitis A, B, and C differs between regions. For this reason, each region should assemble its own rates. Therefore, this study aimed to determine the seroprevalence of hepatitis A, B, and C in children in Kastamonu province, to evaluate whether there is a change in prevalence according to years and patient age, and to review whether there is a change in hepatitis A virus seroprevalence with hepatitis A vaccination. Material and Methods: File records of all patients under 18 whose hepatitis serology was studied at Kastamonu Training and Research Hospital between 01.01.2012 and 21.12.2021 were reviewed retrospectively. Results: A total of 19885 patients and 55738 test results were included in the study. Accordingly, hepatitis A seroprevalence increased year by year. Anti-HAV IgG positivity was higher in the vaccinated group, whereas anti-HAV IgM positivity was higher in the unvaccinated group (p</jats:p>"],"publicationDate":"2022-09-22","publisher":"Medical Records - International Medical Journal","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_abf2","label":"OPEN","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Medical Records","issnPrinted":null,"issnOnline":"2687-4555","issnLinking":null,"ep":"497","iss":null,"sp":"493","vol":"4","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::9c460e8e3a22c5c3fe5f8adead5140f3","originalIds":["10.37990/medr.1159364","50|doiboost____|9c460e8e3a22c5c3fe5f8adead5140f3"],"pids":[{"scheme":"doi","value":"10.37990/medr.1159364"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":3,"influence":2.6553932e-9,"popularity":4.1690447e-9,"impulse":3,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C4"}},"instances":[{"pids":[{"scheme":"doi","value":"10.37990/medr.1159364"}],"type":"Article","urls":["https://doi.org/10.37990/medr.1159364"],"publicationDate":"2022-09-22","refereed":"peerReviewed"}],"isGreen":false,"isInDiamondJournal":false} | |
| local.import.source | OpenAire |
